Image Dominic Tyer An editor and writer specialising in pharma, biotech and healthcare, Dominic Tyer is pharmaphorum's creative and editorial director and interim managing editor. News Havas Lynx Group promotes Jon Chapman and Paul Kinsella Havas Lynx Group has promoted its executive creative director (ECD) duo of Jon Chapman and Paul Kinsella to chief creative officers (CCOs). News EPG Health launches personalised HCP website Medthority Digital medical publisher EPG Health has launched a new independent website for doctors called Medthority. News Jeff Anderson joins OPEN Health in European lead role Jeff Anderson has joined OPEN Health as European Lead for its OPEN VIE and Pharmerit Europe practices. News Kanga Health promotes Paul Allen to management team UK-based digital healthcare agency Kanga Health has promoted Paul Allen to its board of directors and executive management team. Load more results
News Havas Lynx Group promotes Jon Chapman and Paul Kinsella Havas Lynx Group has promoted its executive creative director (ECD) duo of Jon Chapman and Paul Kinsella to chief creative officers (CCOs).
News EPG Health launches personalised HCP website Medthority Digital medical publisher EPG Health has launched a new independent website for doctors called Medthority.
News Jeff Anderson joins OPEN Health in European lead role Jeff Anderson has joined OPEN Health as European Lead for its OPEN VIE and Pharmerit Europe practices.
News Kanga Health promotes Paul Allen to management team UK-based digital healthcare agency Kanga Health has promoted Paul Allen to its board of directors and executive management team.
News AZ claims another win for Imfinzi in frontline liver cancer AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
